Entheon Biomedical Corp. announced that Ruth Chun has resigned as a director of the Company effective February 28, 2023. The Company benefitted from Ms. Chun's expertise in corporate and legal matters and would like to thank her for her contributions and services as a director of Entheon.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.165 CAD | -23.26% | -23.26% | +65.00% |
04-29 | Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 29, 2024 | CI |
04-18 | Entheon Biomedical Corp. announced that it has received CAD 0.1475 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
+65.00% | 1.07M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- ENBI Stock
- News Entheon Biomedical Corp.
- Entheon Biomedical Corp. Announces Resignation of Ruth Chun as Director